3/9/2026Abbisko's Pimicotinib Phase 3 MANEUVER Results Published in The Lancet

3/9/2026Merck KGaA Drops Hengrui-Licensed PARP1 Candidate After Early Clinical...

3/9/2026Hansoh Reports Positive Phase 3 Results for Weekly GLP-1/GIP Dual Agon...

3/9/2026Hansoh's B7-H3 ADC Shows Promising Lung Cancer Activity in Cancer Cell...

3/9/2026iCamuno Biothera Raises Over CNY 100M in Series A3 to Advance iPSC Cel...

3/9/2026Rapport Licenses Seizure Drug Candidate to Tenacia in Greater China

3/9/2026Kelun Biotech and Harbour BioMed's SKB575 Receives IND Clearance in Ch...

3/9/2026Regeneron Highlights Positive Chinese Phase III Data for Obesity Candi...

3/9/2026Biocytogen Achieves Key Clinical Milestone as IDEAYA Initiates Phase I...

3/9/2026NMPA Seeks Input on Draft Guidelines for Quality Summaries of Therapeu...

3/9/2026China Publishes 102nd Batch of Reference Formulations for Generics and...

3/6/2026Sciwind's Ecnoglutide Approved in China for Obesity

3/6/2026Lynk's Zemprocitinib Meets Phase III Endpoints in Atopic Dermatitis

3/6/2026Abbisko Doses First Patient in Trial of KRAS G12D Inhibitor ABSK141

3/6/2026China Approves Novo's Weekly Insulin–GLP-1 Combination Therapy for Ty...

3/6/2026Recent Executive Moves

3/5/2026CDE Issues Guidance on Subject Selection for Oncology Drug Bioequivale...

3/5/2026CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug

3/4/2026Eli Lilly Advances New Oral Diabetes Therapy in China

3/4/2026Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...

3/4/2026Antengene Strikes $1.1B+ CD19 T-Cell Engager Deal with UCB

3/4/2026Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...

3/4/2026Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...

3/4/2026Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...

3/4/2026CDE Issues Technical Guideline on Clinical Trials for Drugs Treating C...

3/4/2026CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...

3/4/2026CSPC's Emicizumab Injection Receives Clinical Trial Approval in China

3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026

3/3/2026China Approves Five NMEs in February as Innovation Expands Globally

3/3/2026Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...

Page:2/822 Total number of articles:24634: [First][<<] [1] [2] [3] [4] [5] [>>] [End]